VRCA - Verrica Pharmaceuticals Inc.

QQQ $ 455.25 $ 2.72 (0.6 %)

DIA $ 409.08 $ 4.58 (1.13 %)

SPY $ 546.60 $ 1.93 (0.35 %)

TLT $ 99.96 $ 0.58 (0.58 %)

GLD $ 231.58 $ 0.97 (0.42 %)

Previous Close

$ 1.91

Open

$ 1.94

Bid

$ 1.90 x 311

Ask

$ 1.91 x 600

Day's Range

$ 1.90 - $ 2.01

52 Week Range

$ 1.89 - $ 11.41

Volume

562,742

Average Volume

Market Cap

81.5M

Beta (5Y Monthly)

$ 1.03

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2024	06-30-2024	10-Q
2	05-13-2024	03-31-2024	10-Q
3	02-29-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-09-2023	03-31-2023	10-Q
7	03-06-2023	12-31-2022	10-K
8	11-07-2022	09-30-2022	10-Q
9	08-11-2022	06-30-2022	10-Q
10	05-09-2022	03-31-2022	10-Q
11	03-02-2022	12-31-2021	10-K
12	11-12-2021	09-30-2021	10-Q
13	08-10-2021	06-30-2021	10-Q
14	05-07-2021	03-31-2021	10-Q
15	03-17-2021	12-31-2020	10-K
16	11-09-2020	09-30-2020	10-Q
17	08-05-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	03-13-2020	12-31-2019	10-K
20	11-06-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-07-2019	03-31-2019	10-Q
23	03-07-2019	12-31-2018	10-K
24	11-07-2018	09-30-2018	10-Q
25	08-07-2018	06-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

top-3-health-care-stocks-which-could-rescue-your-portfolio-this-month

Top 3 Health Care Stocks Which Could Rescu...
08/27/2024 12:54:41

RBC Capital Maintains Outperform on Verric...
08/15/2024 14:59:46

RBC Capital analyst Gregory Renza maintains Verrica Pharmaceuticals (NASDAQ:VRCA) with a Outperform and lowers the price tar...

Needham Maintains Buy on Verrica Pharmaceu...
08/15/2024 09:29:55

Needham analyst Serge Belanger maintains Verrica Pharmaceuticals (NASDAQ:VRCA) with a Buy and lowers the price target from $...

Crude Oil Down Over 1%; Mercury Systems Sh...
08/14/2024 18:45:28

dow-jumps-over-200-points-performance-food-group-shares-gain-after-q4-results

Dow Jumps Over 200 Points; Performance Foo...
08/14/2024 17:53:41

us-stocks-mixed-inflation-rate-falls-more-than-projected

US Stocks Mixed; Inflation Rate Falls More...
08/14/2024 14:06:41

why-is-dermatology-focused-verrica-pharmaceuticals-stock-trading-lower-on-wednesday

Why Is Dermatology-Focused Verrica Pharmac...
08/14/2024 13:52:10

Verrica Pharmaceuticals shares positive preliminary results from Part 2 of its Phase 2 trial for VP-315 in treating basal cell ...

Verrica Pharmaceuticals shares are trading...
08/14/2024 11:57:53

Verrica Pharmaceuticals Q2 Adj $(0.31) Bea...
08/14/2024 11:47:19

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate ...

Verrica's Skin Cancer Treatment VP-315 Sho...
08/14/2024 11:32:46

Verrica Pharmaceuticals Inc. ("Verrica" or "the Company") (NASDAQ:VRCA), a dermatology therapeutics company dev...

Verrica Pharmaceuticals Settles Litigation...
07/01/2024 11:42:38

Verrica Pharmaceuticals Inc. ("Verrica") (NASDAQ:VRCA), a dermatology therapeutics company developing medications for s...

Needham Reiterates Buy on Verrica Pharmace...
05/16/2024 15:41:50

Needham analyst Serge Belanger reiterates Verrica Pharmaceuticals (NASDAQ:VRCA) with a Buy and maintains $16 price target.

Verrica Pharmaceuticals Announces Amendmen...
05/15/2024 11:34:11

planet-fitness-to-rally-around-19-here-are-10-top-analyst-forecasts-for-tuesday

Planet Fitness To Rally Around 19%? Here A...
05/14/2024 13:01:14

HC Wainwright & Co. Maintains Buy on Verri...
05/14/2024 11:02:03

HC Wainwright & Co. analyst Oren Livnat maintains Verrica Pharmaceuticals (NASDAQ:VRCA) with a Buy and raises the price ...

Needham Maintains Buy on Verrica Pharmaceu...
05/14/2024 09:41:38

Needham analyst Serge Belanger maintains Verrica Pharmaceuticals (NASDAQ:VRCA) with a Buy and raises the price target from $...

As Of March 31, 2024, Verrica Pharmaceutic...
05/13/2024 11:33:19

Verrica Pharmaceuticals Q1 2024 GAAP EPS $...
05/13/2024 11:32:11

Needham Reiterates Buy on Verrica Pharmace...
04/10/2024 10:58:12

Needham reiterates Verrica Pharmaceuticals (NASDAQ:VRCA) with a Buy and maintains $8 price target.

Verrica Pharmaceuticals' Lead Product, Yca...
03/26/2024 11:33:42

NCE status provides a minimum of five years of regulatory exclusivity The Company's U.S. patents and pending patent appl...